Related Experiment Videos
Renal transplantation
1George Washington University, 3.5-300, West Wing, Department of Nephrology, Children's National Medical Center, Washington, D.C. 20010, USA. amoudgil@cnmc.org
Insights
Pediatric renal transplantation significantly enhances quality of life for children with end-stage renal disease. Advances in immunosuppression and surgical techniques improve graft survival, but careful pre-transplant evaluation is crucial.
Area of Science:
- Pediatric Nephrology
- Transplantation Immunology
- Surgical Innovation
Background:
- End-stage renal disease (ESRD) in children necessitates renal replacement therapy.
- Renal transplantation is the optimal therapy, improving growth, neurodevelopment, and quality of life.
- Significant advancements have improved patient and graft survival rates.
Purpose of the Study:
- To review the current state of pediatric renal transplantation.
- To highlight key advancements and challenges in the field.
- To emphasize the importance of comprehensive management protocols.
Main Methods:
- Review of current literature on pediatric renal transplantation.
- Discussion of essential pre-transplant criteria and post-transplant management.
- Analysis of common immunosuppressive regimens and potential complications.
Main Results:
- Successful transplantation requires compatible blood groups and negative crossmatch.
- Common immunosuppressants include cyclosporine A/tacrolimus, azathioprine/mycophenolate mofetil, and prednisone.
- Key complications include acute rejection, infections, hypertension, and disease recurrence.
Conclusions:
- Pediatric renal transplantation offers superior outcomes for ESRD.
- Standardized protocols for evaluation, immunosuppression, and infection prevention are essential.
- Socio-economic factors and preemptive living-donor transplantation warrant consideration, especially in developing countries.
Abstract:
Renal transplantation offers the best renal replacement therapy for most children with end stage renal disease improving their potential for growth and nutrition, neurodevelopment and quality of life. Advances in organ retrieval and preservation, improved surgical techniques, newer immunosuppressive drugs and prevention and treatment of infections have significantly improved patient and graft survival. The absolute requirements for a transplant are compatible blood group and a negative cytotoxic crossmatch. The immunosuppressive drugs most often used are cyclosporin A (or tacrolimus), azathioprine (or mycophenolate mofetil) and prednisone. Complications following transplantation include episodes of acute rejection, serious bacterial and viral infections, hypertension and recurrence of primary disease in the allograft. Each centre must have standard protocols for pre-transplant evaluation, management of immunosuppression and prevention of infections. Socio-economic factors should be carefully evaluated before offering transplantation to children in developing countries. Preemptive transplantation from a living donor may be a more viable option for these children.